Evidence map›Paper›PMID 25985846›Full record

ReviewJournal of neurogenetics2015

Using human induced pluripotent stem cells to model cerebellar disease: hope and hype.

Sarah Wiethoff, Charles Arber, Abi Li, Selina Wray, Henry Houlden, Rickie Patani

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neurogenetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sarah Wiethoffa National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology , London , UK.
Charles Arberc Department of Molecular Neuroscience and Queen Square Brain Bank , UCL Institute of Neurology , London , UK.
Abi Lic Department of Molecular Neuroscience and Queen Square Brain Bank , UCL Institute of Neurology , London , UK.
Selina Wrayc Department of Molecular Neuroscience and Queen Square Brain Bank , UCL Institute of Neurology , London , UK.
Henry Houldena National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology , London , UK.
Rickie Patania National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology , London , UK.
National Hospital for Neurology and Neurosurgery · GBUniversity College London · GBUniversity of Tübingen · DE

Funding

Medical Research Council G0802760Medical Research Council G1001253Medical Research Council G108/638Medical Research Council MR/J004758/1Wellcome TrustWellcome Trust 101149/Z/13/Z
6 · The paper itself

Abstract

The cerebellum forms a highly ordered and indispensible component of motor function within the adult neuraxis, consisting of several distinct cellular subtypes. Cerebellar disease, through a variety of genetic and acquired causes, results in the loss of function of defined subclasses of neurons, and remains a significant and untreatable health care burden. The scarcity of therapies in this arena can partially be explained by unresolved disease mechanisms due to inaccessibility of human cerebellar neurons in a relevant experimental context where initiating disease mechanisms could be functionally elucidated, or drug screens conducted. In this review we discuss the potential promise of human induced pluripotent stem cells (hiPSCs) for regenerative neurology, with a particular emphasis on in vitro modelling of cerebellar degeneration. We discuss progress made thus far using hiPSC-based models of neurodegeneration, noting the relatively slower pace of discovery made in modelling cerebellar dysfunction. We conclude by speculating how strategies attempting cerebellar differentiation from hiPSCs can be refined to allow the generation of accurate disease models. This in turn will permit a greater understanding of cerebellar pathophysiology to inform mechanistically rationalised therapies, which are desperately needed in this field.

Indexed as

Cell DifferentiationInduced Pluripotent Stem CellsCerebellar DiseasesHumansCerebellumdirected differentiationdisease modellingiPSC-technologyreprogramming

Identifiers

PMID25985846
PMCPMC4673530
OpenAlexW1891575557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.